$136.32
00.00%
Last update: 5:08 PM
15 minutes delayed
Comments
Loading...
Ascendis Pharma
ASNDNASDAQ
Ascendis Pharma (NASDAQ:ASND) Stock, Earnings Estimates, EPS, And Revenue
Ascendis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS
$-2.500
Quarterly Revenue
$104.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$329M
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma | -$2.35 | — | — | — | $51.66M | — | — | — | 09/03/2024 | Get Alert |
| ASND | Ascendis Pharma | -$2.13 | — | -$2.50 | — | $36.05M | — | $104.15M | — | 05/02/2024 | Get Alert |
| ASND | Ascendis Pharma | -$3.78 | -$2.15 | -$1.66 | 22.79% | $23.37M | $97.02M | $148.22M | 52.77% | 02/07/2024 | Get Alert |
| ASND | Ascendis Pharma | -$3.05 | -$2.75 | -$3.13 | -13.82% | $15.41M | $52.70M | $52.28M | -0.79% | 11/07/2023 | Get Alert |
| ASND | Ascendis Pharma | -$1.56 | -$2.68 | -$2.35 | 1231.34% | $6.57M | $41.73M | $51.66M | 2378.38% | 09/05/2023 | Get Alert |
| ASND | Ascendis Pharma | -$2.48 | — | -$2.13 | — | $7.67M | — | $36.05M | — | 04/27/2023 | Get Alert |
| ASND | Ascendis Pharma | -$2.14 | — | -$3.78 | — | $5.60M | — | $23.37M | — | 02/16/2023 | Get Alert |
| ASND | Ascendis Pharma | -$1.73 | -$2.48 | -$3.05 | -22.98% | $1.31M | — | $15.41M | — | 11/02/2022 | Get Alert |
| ASND | Ascendis Pharma | -$3.01 | -$2.17 | -$1.56 | 28.11% | $1.23M | $5.92M | $6.57M | 10.90% | 08/10/2022 | Get Alert |
| ASND | Ascendis Pharma | -$1.41 | — | -$2.48 | — | $899.60K | — | $7.67M | — | 05/11/2022 | Get Alert |
| ASND | Ascendis Pharma | -$3.15 | -$2.63 | -$2.14 | 18.63% | $637.88K | $2.98M | $5.60M | 87.95% | 03/02/2022 | Get Alert |
| ASND | Ascendis Pharma | -$2.70 | — | -$1.73 | — | $3.22B | — | $1.31M | — | 11/10/2021 | Get Alert |
| ASND | Ascendis Pharma | -$2.17 | -$2.75 | -$3.01 | -9.45% | $1.58M | $1.46M | $1.23M | -15.68% | 08/25/2021 | Get Alert |
| ASND | Ascendis Pharma | -$1.46 | -$2.08 | -$1.41 | 32.21% | $2.45M | $2.30M | $899.60K | -60.89% | 05/27/2021 | Get Alert |
| ASND | Ascendis Pharma | -$1.89 | -$1.83 | -$3.15 | -72.13% | $2.78M | $1.99M | $637.88K | -67.95% | 03/10/2021 | Get Alert |
| ASND | Ascendis Pharma | -$0.58 | -$1.86 | -$2.70 | -45.16% | $2.24M | $1.66M | $3.22M | 94.10% | 11/11/2020 | Get Alert |
| ASND | Ascendis Pharma | -$1.39 | -$1.70 | -$2.17 | -27.65% | $3.56M | $2.53M | $1.58M | -37.51% | 08/27/2020 | Get Alert |
| ASND | Ascendis Pharma | -$1.38 | -$1.50 | -$1.46 | 2.67% | $6.01M | $2.07M | $2.45M | 18.55% | 05/19/2020 | Get Alert |
| ASND | Ascendis Pharma | -$0.85 | -$1.19 | -$1.89 | -58.82% | $11.78M | $1.25M | $2.78M | 122.64% | 04/01/2020 | Get Alert |
| ASND | Ascendis Pharma | -$0.92 | — | -$0.58 | — | $22.80K | — | $2.44M | — | 11/18/2019 | Get Alert |
| ASND | Ascendis Pharma | -$0.64 | — | -$1.39 | — | $21.06K | — | $3.56M | — | 08/28/2019 | Get Alert |
Ascendis Pharma (ASND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-07 | $-1.66 | $-2.15 | 22.8 % |
| Sep 2023 | 2023-11-07 | $-3.13 | $-2.75 | -13.8 % |
| Jun 2023 | 2023-09-05 | $-2.35 | $-2.68 | 1231.3 % |
| Sep 2022 | 2022-11-02 | $-3.05 | $-2.48 | -23.0 % |
Ascendis Pharma (ASND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-07 | $148.22M | $97.02M | 52.8 % |
| Sep 2023 | 2023-11-07 | $52.28M | $52.70M | -0.79 % |
| Jun 2023 | 2023-09-05 | $51.66M | $41.73M | 2378.4 % |
| Jun 2022 | 2022-08-10 | $6.57M | $5.92M | 10.9 % |
FAQ
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma (ASND) is scheduled to report earnings on September 3, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Ascendis Pharma (NASDAQ:ASND)?
The Actual EPS was $-2.50, which missed the estimate of $0.00.
What were Ascendis Pharma’s (NASDAQ:ASND) revenues?
The Actual Revenue was $104.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.